Cargando…
Aberrant overexpression of an epithelial marker, 14-3-3σ, in a subset of hematological malignancies
BACKGROUND: 14-3-3σ is a p53-mediated cell-cycle inhibitor in epithelial cells. The expression of 14-3-3σ is frequently altered in cancers of epithelial origin associated with altered DNA methylation. Since its involvement in a non-epithelial tumor is unknown, we examined 14-3-3σ expression in patie...
Autores principales: | Motokura, Toru, Nakamura, Yukari, Sato, Hiroyuki |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222637/ https://www.ncbi.nlm.nih.gov/pubmed/18036248 http://dx.doi.org/10.1186/1471-2407-7-217 |
Ejemplares similares
-
Frequent downregulation of 14-3-3 σ protein and hypermethylation of 14-3-3 σ gene in salivary gland adenoid cystic carcinoma
por: Uchida, D, et al.
Publicado: (2004) -
Overexpression of 14-3-3σ Modulates Cholangiocarcinoma Cell Survival by PI3K/Akt Signaling
por: Wu, Qiao, et al.
Publicado: (2020) -
14-3-3σ and Its Modulators in Cancer
por: Aljabal, Ghazi, et al.
Publicado: (2020) -
Aberrant Upregulation of 14-3-3σ and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma
por: Zhang, Yi, et al.
Publicado: (2014) -
Methylation of 14-3-3σ gene and prognostic significance of 14-3-3σ expression in non-small cell lung cancer
por: Raungrut, Pritsana, et al.
Publicado: (2017)